Company: EUDAW
Filing Date: 2025-12-04
Form Type: 6-K
Source: 0001493152-25-026218
Chunk: 1

Company: EUDA Health Holdings Ltd
Filing Date: 2025-12-04
Form: 6-K
Chunk 1
---
 right to repurchase any remaining portion of the outstanding Warrant in cash for $0.0625 per
Warrant Share under the Warrant. At the end of the Repurchase Period (the “Expiration Date”) and provided that there are
remaining outstanding Warrant Shares exercisable under the Warrant, the Purchaser will automatically be deemed to have made a “cashless”
exercise of the Warrant, and the Company will be required to issue to the Purchaser one (1) ordinary share for every ten (10) outstanding
Warrant Shares exercised under the Warrant. in the event of a breach of any term or condition of the Warrant or of any covenant of the
Purchase Agreement, the Purchaser will have the right to make a “cashless” exercise of the Warrant and the Company will be
required to issue to Purchaser one (1) ordinary share for every five (5) outstanding Warrant Shares exercised under the Warrant after
sending the Company a notice of the breach and an opportunity to cure within five (5) trading days.

The Company will file a prospectus
supplement relating to the offer and sale of the Warrant and Warrant Shares pursuant to the Purchase Agreement, forming a part
of its Registration Statement on Form F-3 (File No. 333-282723), which was filed with the Securities and Exchange Commission on October
18, 2024 and declared effective on November 4, 2024. In connection with the filing of the prospectus supplement, the Company is filing
a legal opinion of its Utah counsel and BVI counsel, regarding the validity of the Warrant and the validity of the Warrant Shares
upon issuance, both of which are filed as Exhibit 5.1 and 5.2 to this Current Report, respectively incorporated by reference herein.

The foregoing description of the Purchase Agreement and the Warrant does not purport to be complete and is qualified in its entirety by reference to the full text of the Purchase Agreement and the form of Warrant, copies of which are filed as Exhibit 1.1 and 1.2 to this Current Report, respectively and incorporated by reference herein.

This Report on Form 6-K shall not constitute an offer to sell or the solicitation of an offer to buy the ordinary shares (or the Warrant) nor shall there be any sale of the ordinary shares (or the Warrant) in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or